Biomedical Technologies Enhances Lipoprotein Manufacturing Capabilities
News Jun 01, 2015
Preparative ultracentrifuges are used in biology for gradient separations, where the molecules in a sample are separated using a substance of graduated density, such as salt gradients for proteins. The process is often gradual and involves many sequential steps to obtain the desired gradient. BT is now able to double its lipoprotein manufacturing capability and significantly reduce lead times for both standard and custom products.
The lipoprotein manufacturing process is now 24 hours a day, 7 days a week to meet customers' demands.
Kristy McGuire, Laboratory Manager, commented: 'We are committed to our customers and believe that investing in the second ultracentrifuge will enhance our manufacturing capabilities and reduce the lead time on custom products, ultimately resulting in our customers receiving a first class service that exceeds their expectations.
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE